As of November 2024, Rigel Pharmaceuticals has a market cap of $2.41B. This makes Rigel Pharmaceuticals the world's 4619th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $207.50M | -17.93% |
2023 | $252.84M | -3.33% |
2022 | $261.56M | -43.40% |
2021 | $462.08M | -24.29% |
2020 | $610.29M | 63.55% |
2019 | $373.15M | -6.96% |
2018 | $401.05M | -40.72% |
2017 | $676.56M | 63.03% |
2016 | $415.00M | -21.45% |
2015 | $528.34M | 33.48% |
2014 | $395.82M | -20.35% |
2013 | $496.95M | -56.15% |
2012 | $1.13B | -17.62% |
2011 | $1.38B | 4.78% |
2010 | $1.31B | -20.82% |
2009 | $1.66B | 18.88% |
2008 | $1.39B | -68.49% |
2007 | $4.43B | 113.90% |
2006 | $2.07B | 41.99% |
2005 | $1.46B | -65.77% |
2004 | $4.26B | 27.19% |
2003 | $3.35B | 93.94% |
2002 | $1.73B | -76.34% |
2001 | $7.30B | -53.50% |
2000 | $15.69B | - |